Rmpl Pharma LLP — Lenalidomide Exporter Profile
Indian Pharmaceutical Exporter · #10 for Lenalidomide · $145.7K export value · DGFT Verified
Rmpl Pharma LLP is the #10 Indian exporter of Lenalidomide with $145.7K in export value and 82 verified shipments. Rmpl Pharma LLP holds a 0.0% market share in Lenalidomide exports across 10 countries. The company exports 13 pharmaceutical products worth $438.6K across 3 therapeutic categories.
Rmpl Pharma LLP — Lenalidomide Export Profile: Buyers & Destinations
Where Does Rmpl Pharma LLP Export Lenalidomide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $107.5K | 18 | 73.7% |
| UNITED ARAB EMIRATES | $18.3K | 17 | 12.5% |
| TURKEY | $9.5K | 19 | 6.5% |
| TANZANIA | $4.1K | 5 | 2.8% |
| LEBANON | $3.8K | 7 | 2.6% |
| UGANDA | $1.8K | 9 | 1.3% |
| GHANA | $455 | 2 | 0.3% |
| KENYA | $149 | 1 | 0.1% |
| SOMAALIA | $110 | 2 | 0.1% |
| TOGO | $62 | 2 | 0.0% |
Rmpl Pharma LLP exports Lenalidomide to 10 countries. The largest destination is SAUDI ARABIA accounting for 73.7% of Rmpl Pharma LLP's Lenalidomide shipments, followed by UNITED ARAB EMIRATES (12.5%) and TURKEY (6.5%). These destinations reflect Rmpl Pharma LLP's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lenalidomide from Rmpl Pharma LLP?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF INVOICE RAISED TO | TURKEY | $87.1K | 45 |
| TO THE ORDER | SAUDI ARABIA | $47.1K | 6 |
| TO THE ORDER OF INVOICE | UNITED ARAB EMIRATES | $8.6K | 20 |
| INVOICE RAISED TO | UGANDA | $1.7K | 6 |
Rmpl Pharma LLP supplies Lenalidomide to 4 buyers globally. The largest buyer is TO THE ORDER OF INVOICE RAISED TO (TURKEY), followed by TO THE ORDER (SAUDI ARABIA) and TO THE ORDER OF INVOICE (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lenalidomide Export Value and How Much Does Rmpl Pharma LLP Contribute?
India exported $30.4M worth of Lenalidomide through 2,724 shipments from 237 suppliers to 122 countries, serving 557 buyers globally. Rmpl Pharma LLP contributes $145.7K to this total, accounting for 0.0% of India's Lenalidomide exports. Rmpl Pharma LLP ships Lenalidomide to 10 countries through 4 buyers.
What Is the Average Shipment Value for Rmpl Pharma LLP's Lenalidomide Exports?
Rmpl Pharma LLP's average Lenalidomide shipment value is $1.8K per consignment, based on 82 shipments totaling $145.7K. The largest destination is SAUDI ARABIA (73.7% of Rmpl Pharma LLP's Lenalidomide exports).
How Does Rmpl Pharma LLP Compare to Other Indian Lenalidomide Exporters?
Rmpl Pharma LLP ranks #10 among 237 Indian Lenalidomide exporters with a 0.0% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($9.4M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($8.3M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.2M). Rmpl Pharma LLP processed 82 shipments to 10 destination countries.
What Lenalidomide Formulations Does Rmpl Pharma LLP Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VELIMIDE 25MG 30CAP LENALIDOMIDE 94 | $15.6K | 1 |
| VELIMIDE 25MG 30CAP LENALIDOMIDE 45 | $15.0K | 2 |
| VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (673 PACKX30=20190 CAPS) | $10.9K | 1 |
| VELIMIDE 10MG 30CAP LENALIDOMIDE 4 | $10.8K | 2 |
| VELIMIDE 25MG (LENALIDOMIDE) (500 PACKX3 | $8.2K | 1 |
| VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (43 | $7.3K | 1 |
| VELIMIDE 10MG (30CAP) (LENALIDOMIDE) (583 PACKX30=17490 CAPS) | $6.9K | 1 |
| VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (416 PACKX30=12480 CAPS) | $6.8K | 1 |
| LENALID 10MG (30CAP) (LENALIDOMIDE) (15 | $6.1K | 1 |
| VELIMIDE 10MG (LENALIDOMIDE) (500 PACKX | $6.0K | 1 |
Rmpl Pharma LLP exports 69 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VELIMIDE 25MG 30CAP LENALIDOMIDE 94 with 1 shipments worth $15.6K.
How Does Rmpl Pharma LLP Compare to Nearest Lenalidomide Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | DR REDDY S LABORATORIES LIMITED | $150.0K | 3 | 2 | $50.0K |
| 9 | SP ACCURE LABS PRIVATE LIMITED | $149.5K | 7 | 2 | $21.4K |
| 10 | RMPL PHARMA LLP ★ | $145.7K | 82 | 10 | $1.8K |
| 11 | MYLAN LABORATORIES LIMITED | $133.2K | 20 | 6 | $6.7K |
| 12 | BETA DRUGS LIMITED | $110.3K | 66 | 10 | $1.7K |
Rmpl Pharma LLP ranks #10 among 237 Indian Lenalidomide exporters. Average shipment value of $1.8K compared to the market average of $128.1K. The closest competitors by value are DR REDDY S LABORATORIES LIMITED and SP ACCURE LABS PRIVATE LIMITED.
Which Indian Ports Ship Lenalidomide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 740 | 27.2% |
| SAHAR AIR | 688 | 25.3% |
| DELHI AIR CARGO ACC (INDEL4) | 187 | 6.9% |
| Bombay Air | 180 | 6.6% |
| DELHI AIR | 140 | 5.1% |
| Bombay Air Cargo | 88 | 3.2% |
| HYDERABAD ACC (INHYD4) | 78 | 2.9% |
| HYDERABAD AIR | 68 | 2.5% |
What Other Advanced Oncology Products Does Rmpl Pharma LLP Export?
Rmpl Pharma LLP also exports these advanced oncology products. Each links to the detailed product page.
About Rmpl Pharma LLP
Rmpl Pharma LLP exports 13 products worth $438.6K. Beyond Lenalidomide, top products include Rituximab, Daratumumab, Cladribine, Ibrutinib, Dacarbazine. View the complete Rmpl Pharma LLP profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lenalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Rmpl Pharma LLP matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 82 individual customs records matching Rmpl Pharma LLP exporting Lenalidomide, covering 69 formulations to 10 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 557+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lenalidomide Export Data from Rmpl Pharma LLP
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Rmpl Pharma LLP's Lenalidomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Rmpl Pharma LLP
Full Company Profile →
13 products · $438.6K total trade · 3 categories
Lenalidomide Stats
Company Overview
Top Products by Rmpl Pharma LLP
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Rmpl Pharma LLP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lenalidomide. For current shipment-level data, contact TransData Nexus.